Literature DB >> 9042263

Immunohistochemical p53 overexpression correlated to c-erbB-2 and cathepsin D proteins in colorectal cancer.

M L Caruso1, A M Valentini.   

Abstract

The immunohistochemical overexpression of p53 protein in 42 large bowel cancers was correlated to c-erbB-2, cathepsin D (CD) proteins and other clinical and prognostic parameters. p53 overexpression (found in 60% of specimens) was positively associated with cathepsin D staining in stromal cells from older patients and better differentiated colorectal carcinomas (G1 + G2). Cytoplasmatic staining of c-erbB-2 protein was found in 58% of cases. No staining was observed at the cell membrane level. Our findings suggest that lower p53 expression in G3 carcinomas may be due to a high genomic instability, with the loss of both alleles of the gene. Therefore, these carcinomas were immunohistochemically silent. Although our series was small, the association between p53 nuclear neoplastic cells and CD stromal cells is interesting as regards the possible implications of these markers in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9042263

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  HER-2/neu overexpression is an independent prognostic factor in colorectal cancer.

Authors:  Dong Il Park; Mun Su Kang; Suk Joong Oh; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Won Kon Han; Hungdai Kim; Seung Ho Ryu; Antonia R Sepulveda
Journal:  Int J Colorectal Dis       Date:  2006-09-01       Impact factor: 2.571

2.  Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.

Authors:  Liang Zong; Ping Chen; Da-Xin Wang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.

Authors:  Qingguo Li; Daorong Wang; Jing Li; Ping Chen
Journal:  BMC Cancer       Date:  2011-06-27       Impact factor: 4.430

5.  HER 2/neu protein expression in colorectal cancer.

Authors:  B Schuell; T Gruenberger; W Scheithauer; Ch Zielinski; F Wrba
Journal:  BMC Cancer       Date:  2006-05-08       Impact factor: 4.430

6.  HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.

Authors:  Susan D Richman; Katie Southward; Philip Chambers; Debra Cross; Jennifer Barrett; Gemma Hemmings; Morag Taylor; Henry Wood; Gordon Hutchins; Joseph M Foster; Assa Oumie; Karen G Spink; Sarah R Brown; Marc Jones; David Kerr; Kelly Handley; Richard Gray; Matthew Seymour; Philip Quirke
Journal:  J Pathol       Date:  2016-01-29       Impact factor: 7.996

7.  Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

Authors:  Dara O Kavanagh; Gillian Chambers; Liam O'Grady; Kevin M Barry; Ronan P Waldron; Fadel Bennani; Paul W Eustace; Iqdam Tobbia
Journal:  BMC Cancer       Date:  2009-01-01       Impact factor: 4.430

8.  Detection of deregulated modules using deregulatory linked path.

Authors:  Yuxuan Hu; Lin Gao; Kai Shi; David K Y Chiu
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

9.  Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases.

Authors:  Won-Suk Lee; Yeon Ho Park; Jung Nam Lee; Jeong-Heum Baek; Tae-Hoon Lee; Seung Yeon Ha
Journal:  Cancer Med       Date:  2014-03-25       Impact factor: 4.452

Review 10.  Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives.

Authors:  Gianluca Pellino; Gaetano Gallo; Pierlorenzo Pallante; Raffaella Capasso; Alfonso De Stefano; Isacco Maretto; Umberto Malapelle; Shengyang Qiu; Stella Nikolaou; Andrea Barina; Giuseppe Clerico; Alfonso Reginelli; Antonio Giuliani; Guido Sciaudone; Christos Kontovounisios; Luca Brunese; Mario Trompetto; Francesco Selvaggi
Journal:  Gastroenterol Res Pract       Date:  2018-06-13       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.